A citation-based method for searching scientific literature

Wilma L Suarez-Pinzon, Robert F Power, Yanhua Yan, Clive Wasserfall, Mark Atkinson, Alex Rabinovitch. Diabetes 2008
Times Cited: 132







List of co-cited articles
1061 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity



The novel GLP-1-gastrin dual agonist, ZP3022, increases β-cell mass and prevents diabetes in db/db mice.
K Fosgerau, L Jessen, J Lind Tolborg, T Østerlund, K Schæffer Larsen, K Rolsted, M Brorson, J Jelsing, T Skovlund Ryge Neerup. Diabetes Obes Metab 2013
56
48



Combination therapy with epidermal growth factor and gastrin increases beta-cell mass and reverses hyperglycemia in diabetic NOD mice.
Wilma L Suarez-Pinzon, Yanhua Yan, Robert Power, Stephen J Brand, Alex Rabinovitch. Diabetes 2005
118
20

Pantoprazole improves glycemic control in type 2 diabetes: a randomized, double-blind, placebo-controlled trial.
Pawan Kumar Singh, Debasish Hota, Pinaki Dutta, Naresh Sachdeva, Amitava Chakrabarti, Anand Srinivasan, Inderjeet Singh, Anil Bhansali. J Clin Endocrinol Metab 2012
41
46


Pancreatic gastrin stimulates islet differentiation of transforming growth factor alpha-induced ductular precursor cells.
T C Wang, S Bonner-Weir, P S Oates, M Chulak, B Simon, G T Merlino, E V Schmidt, S J Brand. J Clin Invest 1993
231
18




Exendin-4 improves reversal of diabetes in NOD mice treated with anti-CD3 monoclonal antibody by enhancing recovery of beta-cells.
Nicole A Sherry, Wei Chen, Jake A Kushner, Mariela Glandt, Qizhi Tang, Sue Tsai, Pere Santamaria, Jeffrey A Bluestone, Anne-Marie B Brillantes, Kevan C Herold. Endocrinology 2007
138
13

Treatment with a proton pump inhibitor improves glycaemic control in Psammomys obesus, a model of type 2 diabetes.
T B Bödvarsdóttir, K D Hove, C F Gotfredsen, L Pridal, A Vaag, A E Karlsen, J S Petersen. Diabetologia 2010
32
40

Gastrin treatment stimulates β-cell regeneration and improves glucose tolerance in 95% pancreatectomized rats.
Noèlia Téllez, Géraldine Joanny, Jéssica Escoriza, Marina Vilaseca, Eduard Montanya. Endocrinology 2011
34
38


The novel GLP-1-gastrin dual agonist ZP3022 improves glucose homeostasis and increases β-cell mass without affecting islet number in db/db mice.
Louise S Dalbøge, Dorthe L C Almholt, Trine S R Neerup, Niels Vrang, Jacob Jelsing, Keld Fosgerau. J Pharmacol Exp Ther 2014
30
43


Cure of overt diabetes in NOD mice by transient treatment with anti-lymphocyte serum and exendin-4.
Norihiko Ogawa, James F List, Joel F Habener, Takashi Maki. Diabetes 2004
127
12

Biology of incretins: GLP-1 and GIP.
Laurie L Baggio, Daniel J Drucker. Gastroenterology 2007
12

Proton pump inhibitor therapy associated with lower glycosylated hemoglobin levels in type 2 diabetes.
Michael A Crouch, Ivan N Mefford, Ekpedeme U Wade. J Am Board Fam Med 2012
32
37

Beta-cell deficit and increased beta-cell apoptosis in humans with type 2 diabetes.
Alexandra E Butler, Juliette Janson, Susan Bonner-Weir, Robert Ritzel, Robert A Rizza, Peter C Butler. Diabetes 2003
12


Cholecystokinin and gastrin receptors.
Marlène Dufresne, Catherine Seva, Daniel Fourmy. Physiol Rev 2006
305
11

Combination treatment of db/db mice with exendin-4 and gastrin preserves β-cell mass by stimulating β-cell growth and differentiation.
Motoyuki Tamaki, Yoshio Fujitani, Toyoyoshi Uchida, Takahisa Hirose, Ryuzo Kawamori, Hirotaka Watada. J Diabetes Investig 2010
16
68

A new glucagon and GLP-1 co-agonist eliminates obesity in rodents.
Jonathan W Day, Nickki Ottaway, James T Patterson, Vasily Gelfanov, David Smiley, Jas Gidda, Hannes Findeisen, Dennis Bruemmer, Daniel J Drucker, Nilika Chaudhary,[...]. Nat Chem Biol 2009
349
11

Proton pump inhibitors as a treatment method for type II diabetes.
Ivan N Mefford, Ekpedeme U Wade. Med Hypotheses 2009
35
31

The biology of incretin hormones.
Daniel J Drucker. Cell Metab 2006
11

Reversal of new-onset diabetes through modulating inflammation and stimulating beta-cell replication in nonobese diabetic mice by a dipeptidyl peptidase IV inhibitor.
Lei Tian, Jie Gao, Jianqiang Hao, Yu Zhang, Huimin Yi, Timothy D O'Brien, Robert Sorenson, Jian Luo, Zhiguang Guo. Endocrinology 2010
84
11


Glucagon-like peptide 1/glucagon receptor dual agonism reverses obesity in mice.
Alessandro Pocai, Paul E Carrington, Jennifer R Adams, Michael Wright, George Eiermann, Lan Zhu, Xiaobing Du, Aleksandr Petrov, Michael E Lassman, Guoqiang Jiang,[...]. Diabetes 2009
256
10

The physiology of glucagon-like peptide 1.
Jens Juul Holst. Physiol Rev 2007
10

Unimolecular dual incretins maximize metabolic benefits in rodents, monkeys, and humans.
Brian Finan, Tao Ma, Nickki Ottaway, Timo D Müller, Kirk M Habegger, Kristy M Heppner, Henriette Kirchner, Jenna Holland, Jazzminn Hembree, Christine Raver,[...]. Sci Transl Med 2013
276
10

A rationally designed monomeric peptide triagonist corrects obesity and diabetes in rodents.
Brian Finan, Bin Yang, Nickki Ottaway, David L Smiley, Tao Ma, Christoffer Clemmensen, Joe Chabenne, Lianshan Zhang, Kirk M Habegger, Katrin Fischer,[...]. Nat Med 2015
300
10


Are proton pump inhibitors a new antidiabetic drug? A cross sectional study.
Diana Boj-Carceller, Pilar Bocos-Terraz, Miguel Moreno-Vernis, Alejandro Sanz-Paris, Pablo Trincado-Aznar, Ramón Albero-Gamboa. World J Diabetes 2011
25
36

Conversion of adult pancreatic alpha-cells to beta-cells after extreme beta-cell loss.
Fabrizio Thorel, Virginie Népote, Isabelle Avril, Kenji Kohno, Renaud Desgraz, Simona Chera, Pedro L Herrera. Nature 2010
740
9

Pancreatic gastrin in foetal and neonatal rats.
L I Larsson, J F Rehfeld, F Sundler, R Håkanson. Nature 1976
179
9

A role for glucagon-like peptide-1 in the central regulation of feeding.
M D Turton, D O'Shea, I Gunn, S A Beak, C M Edwards, K Meeran, S J Choi, G M Taylor, M M Heath, P D Lambert,[...]. Nature 1996
9

Rituximab, B-lymphocyte depletion, and preservation of beta-cell function.
Mark D Pescovitz, Carla J Greenbaum, Heidi Krause-Steinrauf, Dorothy J Becker, Stephen E Gitelman, Robin Goland, Peter A Gottlieb, Jennifer B Marks, Paula F McGee, Antoinette M Moran,[...]. N Engl J Med 2009
628
8

Insulin needs after CD3-antibody therapy in new-onset type 1 diabetes.
Bart Keymeulen, Evy Vandemeulebroucke, Anette G Ziegler, Chantal Mathieu, Leonard Kaufman, Geoff Hale, Frans Gorus, Michel Goldman, Markus Walter, Sophie Candon,[...]. N Engl J Med 2005
784
8

Beta-cell growth and regeneration: replication is only part of the story.
Susan Bonner-Weir, Wan-Chun Li, Limor Ouziel-Yahalom, Lili Guo, Gordon C Weir, Arun Sharma. Diabetes 2010
174
8

Treatment with a proton pump inhibitor improves glycaemic control in type 2 diabetic patients - a retrospective analysis.
Karin D Hove, Kristine Færch, Thóra B Bödvarsdóttir, Allan E Karlsen, Jacob S Petersen, Allan Vaag. Diabetes Res Clin Pract 2010
24
33

Adult pancreatic beta-cells are formed by self-duplication rather than stem-cell differentiation.
Yuval Dor, Juliana Brown, Olga I Martinez, Douglas A Melton. Nature 2004
8

Co-stimulation modulation with abatacept in patients with recent-onset type 1 diabetes: a randomised, double-blind, placebo-controlled trial.
Tihamer Orban, Brian Bundy, Dorothy J Becker, Linda A DiMeglio, Stephen E Gitelman, Robin Goland, Peter A Gottlieb, Carla J Greenbaum, Jennifer B Marks, Roshanak Monzavi,[...]. Lancet 2011
347
8

Emerging combinatorial hormone therapies for the treatment of obesity and T2DM.
Sharon A Sadry, Daniel J Drucker. Nat Rev Endocrinol 2013
118
8

GAD treatment and insulin secretion in recent-onset type 1 diabetes.
Johnny Ludvigsson, Maria Faresjö, Maria Hjorth, Stina Axelsson, Mikael Chéramy, Mikael Pihl, Outi Vaarala, Gun Forsander, Sten Ivarsson, Calle Johansson,[...]. N Engl J Med 2008
332
7

Exendin-4 modulates diabetes onset in nonobese diabetic mice.
Irene Hadjiyanni, Laurie L Baggio, Philippe Poussier, Daniel J Drucker. Endocrinology 2008
79
8

Dipeptidyl peptidase IV inhibitor treatment stimulates beta-cell survival and islet neogenesis in streptozotocin-induced diabetic rats.
J Andrew Pospisilik, Jennifer Martin, Timothy Doty, Jan A Ehses, Nathalie Pamir, Francis C Lynn, Shalea Piteau, Hans-Ulrich Demuth, Christopher H S McIntosh, Raymond A Pederson. Diabetes 2003
271
7

Effects of exenatide alone and in combination with daclizumab on beta-cell function in long-standing type 1 diabetes.
Kristina I Rother, Lisa M Spain, Robert A Wesley, Benigno J Digon, Alain Baron, Kim Chen, Patric Nelson, H-Michael Dosch, Jerry P Palmer, Barbara Brooks-Worrell,[...]. Diabetes Care 2009
95
7



Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.